Cantargia AB logo

CANTA - Cantargia AB Share Price

SEK55 2.0  3.8%

Last Trade - 10:35am

Mid Cap
Market Cap £422.2m
Enterprise Value £382.1m
Revenue £n/a
Position in Universe 462nd / 1772
Unlock CANTA Revenue
Relative Strength (%)
1m +36.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 950
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Cantargia AB revenues was not reported. Net loss increased 59% to SEK77M. Higher net loss reflects Research and Development Costs increase of 68% to SEK69.8M (expense), Administrative costs increase of 6% to SEK7.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -SEK0.70 to -SEK0.90.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CANTA
Graphical History


CANTA Revenue Unlock CANTA Revenue

Net Income

CANTA Net Income Unlock CANTA Revenue

Normalised EPS

CANTA Normalised EPS Unlock CANTA Revenue

PE Ratio Range

CANTA PE Ratio Range Unlock CANTA Revenue

Dividend Yield Range

CANTA Dividend Yield Range Unlock CANTA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CANTA EPS Forecasts Unlock CANTA Revenue
Profile Summary

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since March 17, 2015
No. of Shareholders: 5,406
No. of Employees: 15
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 91,005,489
Free Float (0.0%)
Eligible for
CANTA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CANTA
Upcoming Events for CANTA
Frequently Asked Questions for Cantargia AB
What is the Cantargia AB share price?

As of 10:35am, shares in Cantargia AB are trading at SEK55, giving the company a market capitalisation of £422.2m. This share price information is delayed by 15 minutes.

How has the Cantargia AB share price performed this year?

Shares in Cantargia AB are currently trading at SEK55 and the price has moved by 0.262k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cantargia AB price has moved by 0.293k% over the past year.

What are the analyst and broker recommendations for Cantargia AB?

Of the analysts with advisory recommendations for Cantargia AB, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cantargia AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cantargia AB next release its financial results?

Cantargia AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Cantargia AB dividend yield?

Cantargia AB does not currently pay a dividend.

Does Cantargia AB pay a dividend?

Cantargia AB does not currently pay a dividend.

When does Cantargia AB next pay dividends?

Cantargia AB does not currently pay a dividend.

How do I buy Cantargia AB shares?

To buy shares in Cantargia AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cantargia AB?

Shares in Cantargia AB are currently trading at SEK55, giving the company a market capitalisation of £422.2m.

Where are Cantargia AB shares listed? Where are Cantargia AB shares listed?

Here are the trading details for Cantargia AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CANTA
What kind of share is Cantargia AB?

Based on an overall assessment of its quality, value and momentum, Cantargia AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cantargia AB share price forecast 2020?

Shares in Cantargia AB are currently priced at SEK55. At that level they are trading at 9.43% discount to the analyst consensus target price of 0.00.

Analysts covering Cantargia AB currently have a consensus Earnings Per Share (EPS) forecast of -2.677 for the next financial year.

How can I tell whether the Cantargia AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cantargia AB. Over the past six months, the relative strength of its shares against the market has been 0.187k%. At the current price of SEK55, shares in Cantargia AB are trading at 0.116k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cantargia AB PE Ratio?

We were not able to find PE ratio data for Cantargia AB.

Who are the key directors of Cantargia AB?

Cantargia AB's management team is headed by:

Thoas Fioretos - DRC
Claus Andersson - DRC
Goran Forsberg - CEO
Liselotte Larsson - COO
Lars Thorsson - VPR
David Liberg - VPR
Karin Leandersson - DRC
Magnus Persson - CHM
Bengt Jondell - CFO
Patricia Delaite - DRC
Anders Martin-Lof - DRC
Ignacio Garcia-Ribas - OTH
Susanne Lagerlund - VPR
Peter Madsen - VPR
Who are the major shareholders of Cantargia AB?

Here are the top five shareholders of Cantargia AB based on the size of their shareholding:

Fjärde AP-Fonden Pension Fund
Percentage owned: 7.75% (7.06m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 7.43% (6.77m shares)
Alecta pensionsförsäkring, ömsesidigt Investment Advisor
Percentage owned: 6.64% (6.05m shares)
Första AP-Fonden Pension Fund
Percentage owned: 6.31% (5.75m shares)
Avanza Bank Holding AB Corporation
Percentage owned: 4.4% (4.01m shares)
Similar to CANTA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.